<DOC>
	<DOCNO>NCT00094146</DOCNO>
	<brief_summary>This study patient least moderate obesity ( Body Mass Index [ BMI ] &gt; 30 kg/m2 approximately 30 pound overweight ) also produce much insulin ( insulin store sugar fat ) . Sandostatin LAR速 Depot suppress insulin , develop help weight loss people find hard lose weight produce much insulin . The main purpose study find low dose Sandostatin LAR速 Depot safely help overweight people lose weight . The study also compare weight loss obese patient receive one three different dosage Sandostatin LAR Depot placebo .</brief_summary>
	<brief_title>Sandostatin LAR速 Depot Patients With Primary Insulin Hypersecretion ( PIH ) Least Moderate Obesity</brief_title>
	<detailed_description />
	<mesh_term>Obesity</mesh_term>
	<mesh_term>Octreotide</mesh_term>
	<criteria>You may qualify study : age 1870 ( male female ) least moderately obese ( BMI &gt; 30 kg/m2 approximately 30 pound overweight ) pass oral glucose tolerance test ( 3 hour test determine body produce much insulin ) You qualify study : diabetes able lose weight diet exercise alone previously receive Sandostatin LAR速 Depot</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2004</verification_date>
	<keyword>Primary Insulin Hypersecretion</keyword>
	<keyword>PIH</keyword>
	<keyword>Obesity</keyword>
</DOC>